BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
See today's BioWorld Asia
Home
» China Resources Hong Kong IPO rakes in $1.8B
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
China Resources Hong Kong IPO rakes in $1.8B
Nov. 2, 2016
By
Pearl Liu
No Comments
HONG KONG – Shares of China Resources Pharmaceutical Group Ltd. (HK:3320) sank in their trading debut on Oct. 28 after raising about $1.8 billion in Hong Kong, making it the largest IPO from a drugmaker in Asia this year.
BioWorld Asia